Abstract:Purpose:To assess the effect of lung volume on measured values and repeatability of xenon 129 (129Xe) gas uptake metrics in healthy volunteers and participants with chronic obstructive pulmonary disease (COPD).Materials and Methods:This Health Insurance Portability and Accountability Act-compliant prospective study included data (March 2014-December 2015) from 49 participants (19 with COPD [mean age, 67 years ± 9 (SD)]; nine women]; 25 older healthy volunteers [mean age, 59 years ± 10; 20 women]; and five young healthy women [mean age, 23 years ± 3]). Thirty-two participants underwent repeated 129Xe and same-breath-hold proton MRI at residual volume plus one-third forced vital capacity (RV+FVC/3), with 29 also undergoing one examination at total lung capacity (TLC). The remaining 17 participants underwent imaging at TLC, RV+FVC/3, and residual volume (RV). Signal ratios between membrane, red blood cell (RBC), and gas-phase compartments were calculated using hierarchical iterative decomposition of water and fat with echo asymmetry and least-squares estimation (ie, IDEAL). Repeatability was assessed using coefficient of variation and intraclass correlation coefficient, and volume relationships were assessed using Spearman correlation and Wilcoxon rank sum tests.Results:Gas uptake metrics were repeatable at RV+FVC/3 (intraclass correlation coefficient = 0.88 for membrane/gas; 0.71 for RBC/gas, and 0.88 for RBC/membrane). Relative ratio changes were highly correlated with relative volume changes for membrane/gas (r = -0.97) and RBC/gas (r = -0.93). Membrane/gas and RBC/gas measured at RV+FVC/3 were significantly lower in the COPD group than the corresponding healthy group (P ≤ .001). However, these differences lessened upon correction for individual volume differences (P = .23 for membrane/gas; P = .09 for RBC/gas).Conclusion:Dissolved-phase 129Xe MRI-derived gas uptake metrics were repeatable but highly dependent on lung volume during measurement.Keywords: Blood-Air Barrier, MRI, Chronic Obstructive Pulmonary Disease, Pulmonary Gas Exchange, Xenon Supplemental material is available for this article © RSNA, 2023.

The pharmacokinetics of hyperpolarized xenon: Implications for cerebral MRI

Probing Changes in Lung Physiology in COPD Using CT, Perfusion MRI, and Hyperpolarized Xenon-129 MRI

Lung Volume Dependence and Repeatability of Hyperpolarized 129xe MRI Gas Uptake Metrics in Healthy Volunteers and Participants with COPD.

Xenon Effects on Regional Cerebral Blood Flow Assessed by 15O‐H2O Positron Emission Tomography: Implications for Hyperpolarized Xenon MRI

Magnetization and Diffusion Effects in Nmr Imaging of Hyperpolarized Substances

Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129

Considerations for hyperpolarized 13 C MR at reduced field: Comparing 1.5T versus 3T

Mode-Dependent Effect of Xenon Inhalation on Kainic Acid-Induced Status Epilepticus in Rats

Oxygen-Enhanced Magnetic Resonance Imaging of the Brain: A Rodent Model

Xenon exerts anti-seizure and neuroprotective effects in kainic acid-induced status epilepticus and neonatal hypoxia-induced seizure.

Analytical corrections for B1‐inhomogeneity and signal decay in multi‐slice 2D spiral hyperpolarized 129Xe MRI using keyhole reconstruction

A pharmacokinetic model for hyperpolarized 13C‐pyruvate MRI when using metabolite‐specific bSSFP sequences

Hyperpolarized Metabolic MRI—Acquisition, Reconstruction, and Analysis Methods

Effect of inhaled oxygen level on dynamic glucose‐enhanced MRI in mouse brain

Measuring Glycolytic Activity with Hyperpolarized [2H7, U-13C6] D-Glucose in the Naive Mouse Brain under Different Anesthetic Conditions

Sensitivity analysis of models of gas exchange for lung hyperpolarised 129Xe MR

Compressed sensing reconstruction for high‐SNR, rapid dissolved 129Xe gas exchange MRI

Overcoming the Challenges of Hyperpolarizing Substrates with Parahydrogen‐Induced Polarization in an MRI System

Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients

Standalone portable xenon-129 hyperpolariser for multicentre clinical magnetic resonance imaging of the lungs

Neuroprotective Properties of Xenon